Novel inositol phospholipid headgroup surrogate crystallized in the pleckstrin homology domain of protein kinase Bα

被引:22
作者
Mills, Stephen J.
Komander, David
Trusselle, Melanie N.
Safrany, Stephen T.
van Aalten, Daan M. F.
Potter, Barry V. L. [1 ]
机构
[1] Univ Bath, Wolfson Lab Med Chem, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England
[2] Univ Dundee, Sch Life Sci, Div Biol Chem & Mol Microbiol, Dundee DD1 5EH, Scotland
[3] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England
关键词
D O I
10.1021/cb700019r
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein kinase B (PKB/Akt) plays a key role in cell signaling. The PH domain of PKB binds phosphatidylinositol 3,4,5-trisphosphate translocating PKB to the plasma membrane for activation by 3-phosphoinositide-dependent protein kinase 1. The crystal structure of the headgroup inositol 1,3,4,5-tetrakisphosphate Ins(1,3,4,5)P-4 PKB complex facilitates in silico ligand design. The novel achiral analogue benzene 1,2,3,4-tetrakisphosphate (Bz(1,2,3,4)P-4) possesses phosphate regiochemistry different from that of Ins(1,3,4,5)P-4 and surprisingly binds with similar affinity as the natural headgroup. Bz(1,2,3,4)P-4 co-crystallizes with the PKB PH domain in a fashion also predictable in silico. The 2-phosphate of Bz(1,2,3,4)P-4 does not interact with any residue, and the D5-phosphate of Ins(1,3,4,5)P-4 is not mimicked by Bz(1,2,3,4)P-4. Bz(1,2,3,4)P-4 is an example of a simple inositol phosphate surrogate crystallized in a protein, and this approach could be applied to design modulators of inositol polyphosphate binding proteins.
引用
收藏
页码:242 / 246
页数:5
相关论文
共 31 条
[1]   3-phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase [J].
Alessi, DR ;
Deak, M ;
Casamayor, A ;
Caudwell, FB ;
Morrice, N ;
Norman, DG ;
Gaffney, P ;
Reese, CB ;
MacDougall, CN ;
Harbison, D ;
Ashworth, A ;
Bownes, M .
CURRENT BIOLOGY, 1997, 7 (10) :776-789
[2]   Role of translocation in the activation and function of protein kinase B [J].
Andjelkovic, M ;
Alessi, DR ;
Meier, R ;
Fernandez, A ;
Lamb, NJC ;
Frech, M ;
Cron, P ;
Cohen, P ;
Lucocq, JM ;
Hemmings, BA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (50) :31515-31524
[3]   The specificities of protein kinase inhibitors: an update [J].
Bain, J ;
McLauchlan, H ;
Elliott, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2003, 371 :199-204
[4]   Regulation of Akt/PKB Ser473 phosphorylation [J].
Bayascas, JR ;
Alessi, DR .
MOLECULAR CELL, 2005, 18 (02) :143-145
[5]   A portrait of AKT kinases - Human cancer and animal models depict a family with strong individualities [J].
Bellacosa, A ;
Testa, JR ;
Moore, R ;
Larue, L .
CANCER BIOLOGY & THERAPY, 2004, 3 (03) :268-275
[6]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[7]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[8]   Specificity and mechanism of action of some commonly used protein kinase inhibitors [J].
Davies, SP ;
Reddy, H ;
Caivano, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2000, 351 (351) :95-105
[9]  
DeLano W. L., 2002, PYMOL
[10]   The regulation of membrane to cytosol partitioning of signalling proteins by phosphoinositides and their soluble headgroups [J].
Downes, CP ;
Gray, A ;
Fairservice, A ;
Safrany, ST ;
Batty, IH ;
Fleming, I .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2005, 33 :1303-1307